Related Experiment Videos
Global and segmental left ventricular function in beta-thalassemia
Insights
Left ventricular function in beta-thalassemia patients remains normal until congestive heart failure develops, which impacts systolic performance. Iron overload
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Beta-thalassemia is a genetic blood disorder requiring frequent transfusions.
- Transfusion therapy can lead to iron overload and cardiac complications.
- Left ventricular (LV) function is crucial in assessing cardiac health.
Purpose of the Study:
- To evaluate systolic and diastolic left ventricular function in beta-thalassemia patients.
- To investigate the impact of congestive heart failure (CHF) on LV function in this population.
- To explore the relationship between iron load and cardiac function.
Main Methods:
- M-mode echocardiography was used to assess LV function.
- 60 beta-thalassemia patients and 30 healthy controls were studied.
- Patients were evaluated 48 hours post-transfusion.
Main Results:
- Enlarged LV dimensions were observed in thalassemic patients with CHF.
- Global LV systolic function deteriorated with CHF onset.
- Segmental LV function and diastolic indices remained largely unaffected by CHF or iron load.
Conclusions:
- Global LV function is preserved in beta-thalassemia until CHF develops.
- CHF onset is associated with impaired LV systolic performance.
- The role of iron overload in CHF development in beta-thalassemia requires further investigation.
Abstract:
The systolic and diastolic left ventricular (LV) function was studied by M-mode echocardiography in 60 patients with beta-thalassemia (mean age +/- SD, 17.1 +/- 7.5 years) and 30 healthy controls (15.4 +/- 3.8 years). In thalassemic patients, echocardiograms were obtained 48 h posttransfusion, with a mean hemoglobin level of 12.4 +/- 0.9 g/dl. To examination time, thalassemic patients had received 30-774 blood units (318 +/- 176). Congestive heart failure (CHF) was present in 14 thalassemic patients (19.6 +/- 3.4 years), while 46 (16.3 +/- 8.2 years) had no clinical signs of CHF. Global LV function study showed enlarged LV dimensions in thalassemic patients with CHF (p less than 0.001) and similar cavity size in controls and patients without CHF (p = NS). The same was true for velocity measurements, while diastolic LV indices had similar values in all groups (p = NS). Segmental LV function study showed no significant differences in systolic and diastolic LV posterior wall behavior between thalassemic patients and controls, and even more, between thalassemic patients with and without CHF, while it was independent of iron load. These findings indicate that global and segmental LV function in thalassemic patients remain within normal limits until the final stages of the disease. CHF onset marks the deterioration of LV systolic performance, while global and segmental diastolic indices do not change significantly. The above findings question the role of iron overload in the development of CHF in beta-thalassemia.